Society Logo
ME/CFS Australia Ltd
Please Click Here To Donate ME/CFS Australia (SA) Inc
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Closed while relocating

Phone:
1300 128 339

Office Hours:
Wednesdays, 10am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 277KB)
Why become a member?
 

New drug approved for Fibromyalgia

Thursday 29 January 2009

SavellaAbout.com’s Guide to Drugs reports on the latest drug to be approved by the U.S. Food and Drug Administration for use in Fibromyalgia.

The drug is Savella (milnacipran hydrochloride), and it was given the all-clear by the FDA on 14 January 2009.

The first drug approved specifically for Fibromyalgiawas Lyrica (pregabalin) – it was approved by the FDA in July 2007. The second was Cymbalta (duloxetine hydrochloride) in June 2008.

You can read more about it here:

About.com: Fibromyalgia: Drugs Approved by the FDA to Manage Pain

The FDA also has an official information page on Fibromyalgia:

U.S. Food and Drug Administration: Living with Fibromyalgia, Drugs Approved to Manage Pain

 


 

blog comments powered by Disqus

 


Arrow right

More Fibromyalgia News
Previous Previous Page